A double safety lock tumor-specific device for suicide gene therapy in breast cancer

Area of Science:

• Biomedicine
• Nanotechnology
• Oncology

Background:

• Cancer treatment faces challenges due to tumor evolution and lack of specificity, leading to systemic toxicity.
• Current therapies often lack tumor specificity, harming healthy cells and causing side effects.

Purpose of the Study:

• To develop a novel, selective nanodevice for targeted elimination of tumor cells.
• To create a multifunctional gene-delivery system that minimizes toxicity to healthy cells.

Main Methods:

• A polyplex carrier was engineered using elastin-like recombinamers (ELRs) covalently conjugated to aptamers, complexed with therapeutic DNA.
• The nanodevice was designed for dual targeting: specific binding to tumor cell markers and selective DNA expression within cancer cells.
• In vitro and in vivo assays were conducted to evaluate the nanodevice's efficacy and toxicity.

Main Results:

• The ELR-based polyplexes demonstrated homogeneous populations and selective toxicity against cancer cells.
• Significant inhibition of tumor progression and dose-dependent reduction in tumor mass were observed.
• Histological studies confirmed specific reduction in tumor parenchyma and markers, indicating targeted action.

Conclusions:

• The developed nanodevice represents a significant advancement in targeted tumor therapy.
• This specialized gene-delivery system offers a potentially efficient and safer approach for cancer treatment.
• Further development of this multifunctional device holds promise for rational cancer therapy design.